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sensory panel. All the compounds tested exhibited antibacterial activity against
eus and Escherichia coli. This activity was shown to be closely dependent on the
W and concentration used. Within 4h at 103 cells/mL, all ﬁve compounds, at every
%, 0.25% and 0.1%, w/v), proved to be bactericidal; for higher inocula, 0.1% (w/v) was
; at 107 or 105 cells/mL, and independently of the inoculum level, 0.25% (w/v) of any
e (COS) mixture was sufﬁcient to reduce the E. coli initial population by at least 3 log
r exhibited bactericidal action over S. aureus, unlike high and medium MW
at 0.5% (w/v), presented a bactericidal effect even against 107 cells/mL. When
uid food matrices, medium and high MW chitosans maintained their activity, for both
ria, although a slower activity was noticeable in milk; however, COS lost their activity
in milk after 4–8h. Furthermore, addition of chitosans to apple juice led to severalunpleasant off-ﬂavors, such as astringency and after taste—which increased in magnitude with MW.Chitin is a natural polymer, found in the exoskeletons of
crustaceans and insects, as well as in the cell walls of certain fungi
(Rinaudo, 2006). Full (or partial) deacetylation of chitin produces
chitosan—a linear polysaccharide composed mainly of b-1,4-
2-deoxy-2-amino-D-glucopyranose, and of b-1,4-2-deoxy-2-
acetamido-D-glucopyranose residues to a lesser extent (Vernazza
et al., 2005). Evidence has been put forward that chitosan
possesses various biological activities, viz. antioxidant (Chien
et al., 2007), cholesterol lowering (Koide, 1998), and antibacterial
and antifungal properties (Liu et al., 2006; Rhoades and Roller,
2000; Tikhonov et al., 2006; Uchida et al., 1989), besides being
useful as an active dietary component for body fat loss (Ormrod
et al., 1998; Woodgate and Conquer, 2003). These features,
combined with its biocompatibility and biodegradability, make
it an interesting polymer for several applications in agriculture
(Pospieszny et al., 1994), as well as in pharmaceutical, cosmetic
(Kim et al., 2006; Ravi-Kumar et al., 2004), food (Devliegherealcata).et al., 2004) and textile (Lim and Hudson, 2004) industries, and
also in medicine (Shi et al., 2006). However, its high-molecular
weight (MW)—most commercial chitosans have indeed a MW
ranging between 100 and 1200kDa (Roller and Covill, 1999), has
limited its practical applications due to its insolubility at pH
values above 6.3 (Okuyama et al., 2000; Seo et al., 2007).
Recent studies have focused on conversion of chitosan to
oligosaccharides (termed chitooligosaccharides, COS)—because
the latter are not only readily soluble in water due to their
shorter chain lengths (generally, the MW of COS is 10 kDa
or less) (Kim and Rajapakse, 2005) and free amino groups in
D-glucosamine units, but also easily absorbed through the
intestine, quickly getting into the blood ﬂow (Chae et al., 2005;
Kim and Rajapakse, 2005). The aforementioned properties, in
addition to the positive charge of COS (which allows them to bind
strongly to negatively charged surfaces), are responsible for many
observed biological activities, such as lowering high blood
pressure (Giustina and Ventura, 1995), controlling arthritis
(Lee et al., 2003), treatment of diabetes mellitus (Liu et al.,
2007) and immuno-stimulation (Suzuki et al., 1986), in addition
to prebiotic activity (Lee et al., 2003). Furthermore, such
oligomers are potentially more advantageous than chitin and
chitosan as nutraceutical food additives because, unlike the
ARTICLE IN PRESSformer, COS are degraded in the human intestine (Shahidi et al.,
1999).
The reported minimum inhibitory concentrations (MICs) of
chitosan vary widely—from 0.005% to 1.5% (w/v) for Staphylococcus
aureus (Chang et al., 1989; Wang, 1992) or from 0.025% to 1.0%
(w/v) for Escherichia coli (Gerasimenko et al., 2003; Uchida et al.,
1989), and its antibacterial effects seem to be closely related to
MW and degree of acetylation (Lee et al., 2002). However, the
results published so far have shown contradictory conclusions:
some authors reported that chitosan is more effective than COS
in inhibiting growth of bacteria—e.g. water-insoluble chitosans
exhibit higher antimicrobial effect over E. coli than COS (Jeon
et al., 2001; Qin et al., 2006), or COS have weak or no antimicrobial
activity (No et al., 2002; Qin et al., 2006); others claimed that an
increase in MW leads to a decrease in the activity of chitosan—e.g.
COS exhibit higher antimicrobial effect over E. coli than water-
insoluble chitosans (Xia andWu,1996; Zheng and Zhu, 2003), or the
high number of amino groups in chitosan molecules (for MW above
91.6kDa) leads to a decrease in antimicrobial activity (Liu et al.,
2001).
On the other hand, the antibacterial activity of chitosan has
been demonstrated almost exclusively in vitro (either using liquid
or solid media); however, such results can hardly be extrapolated
to complex food systems, because interaction of chitosans with
food ingredients will likely interfere with the efﬁcacy of the
former—besides other important changes, which are simulta-
neously brought about by sensory and textural properties of the
food matrix itself. Rhoades and Roller (2000) concluded that
chitosan has a potential for use as food preservative, yet the food
matrix constituents appear to play important roles upon its
antimicrobial capacity. Kisko´ et al. (2005), in turn, suggested
that addition of chitosan to fruit juice during processing may
increase the risk of poisoning by E. coli O157:H7, via knocking out
a portion of the prevailing native yeast population. Ausar et al.
(2002) showed that the inhibiting effects of chitosan upon three
representative milk fermentation bacteria were reversed when
that biopolymer was incubated with milk prior to exposure to
those bacteria. Devlieghere et al. (2004) claimed that the power
of chitosan as food antimicrobial agent is limited to food products
that have low levels of protein and sodium chloride (e.g. fruits and
vegetables), whereas No et al. (2002) reported that the addition of
chitosan to acidic foods enhances its effectiveness as natural
preservative. Finally, Lee et al. (2004) concluded that a packaging
material coated with a combination of nisin and chitosan
improves signiﬁcantly the microbial stability of milk and orange
juice, at 31 and 10 1C.
In view of the above data, this research effort was aimed at
further elucidating the relationship between MWof chitosans and
their antimicrobial activity upon selected common food-borne
spoilage and pathogen microorganisms, as well as the effects
of interaction with food ingredients upon the activity in
typical liquid food products. Our study used S. aureus and
E. coli as model microorganisms (one Gram-positive and one
Gram-negative, respectively), and milk and apple juice as
examples of food matrices (one rich in proteins and one rich in
carbohydrates, respectively)—including, for the ﬁrst time, sensory
tests.Chitosans, characterized by three different MW (average of
628, 591 and 107kDa), and with a degree of deacetylation in the
range 80–85%, were obtained from Sigma-Aldrich (Sintra, Portugal).Chitooligosaccharide mixtures, characterized by two distinct MW
(designated as o5 and o3kDa), and with a degree of deacetyla-
tion in the range 80–85%, were purchased from Nicechem
(Shanghai, China). The chitosans and COS tested were obtained
from crab shells.
Two food matrices were tested—UHT semi-skimmed milk
containing 1.6% (w/v) milkfat, purchased from AGROS (Porto,
Portugal); and pasteurized apple juice, obtained from Compal
(Almeirim, Portugal).
Microorganisms were from NCTC (London, UK), viz. E. coli
(NCTC 9001) and S. aureus (NCTC 8532).In the preparation of chitosan solutions, 2.5% (w/v) chitosans
were dispersed in a 1.0% (v/v) acetic acid solution, whereas COS
solutions were prepared by dissolving 2.5% (w/v) COS in deionized
water. In both cases, the pH was adjusted to 5.8 with 10M NaOH
(the pH most adequate to solubilize chitosan and without any
antibacterial effect). After stirring overnight, the solutions were
autoclaved at 120 1C for 15min (thermostability under these
conditions had been previously checked).MICs were determined as the lowest concentrations of
chitosan or COS at which microorganisms cannot grow in Muller–
Hinton (M–H) broth (Lab M, UK); based on the method of
Ruparelia et al. (2008), the strains were inoculated into M–H broth
and incubated to the logarithmic growth phase at 37 1C. The
growth density was adjusted to match a MacFarland 0.5 standard
(108 CFU/ml). A 1:100 dilution was prepared in a fresh M–H broth,
and used as the inoculum (106CFU/ml); several concentrations
were tested, and microbial growth was monitored via turbidity by
24h of incubation at 37 1C.
Minimum lethal concentrations (MLCs) were determined as
the lowest concentrations of chitosan or COS at which microbial
growth was prevented, and the initial viability was in addition
reduced by at least 99.9% within 24h; it was determined by
inoculation of 100 mL-aliquots of negative tubes (absence of
turbidity in the MIC determination) on M–H agar, using the
spread plate technique.The antimicrobial activities of the three (high, medium and
low MW) chitosans, and of the two (o5 and o3kDa) COS were
tested as described previously by Borbone et al. (2006) with
minor modiﬁcations, against S. aureus and E. coli in M–H broth, at
three different inoculum levels 107, 105 and 103 CFU/mL. Both
strains were adjusted to 108CFU/mL in saline solution (turbidity
equivalent to that of a 0.5 McFarland standard), and were further
diluted at 1:10 to obtain the additional inoculum levels desired in
M–H broth containing the following chitosan/COS concentrations:
0.50%, 0.25% and 0.10% (w/v). Viability counts of chitosan/COS-
containing suspensions were performed at 0, 30, 60, 120 and
240min, by the spread plate technique on plate count agar
(PCA, from Lab M), for 24h at 37 1C. Death curves were
constructed by plotting log (N/N0)—where N is the viable cell
number at a given time and N0 is the viable cell number at time
zero, versus time. Bactericidal activity was deﬁned as a 43 log
cycle decrease of the initial inoculum size.
ARTICLE IN PRESSThe antimicrobial activities of the three chitosans and the two
COS were tested against E. coli and S. aureus in M–H broth (used as
control), as well as in two selected (liquid) food matrices—milk
and apple juice. Both strains were adjusted to 108 CFU/mL in
saline solution (turbidity equivalent to that of a 0.5 McFarland
standard), and were further diluted at 1:10 to obtain 105 CFU/mL
in M–H broth (milk or apple juice) containing 0.50% (w/v) of
chitosan/COS. Viability counts of chitosan/COS-containing sus-
pensions were performed at 0, 1, 2, 4, 8, 24, 48, 72, 96 and 120h,
by the spread plate technique on PCA, for 24h at 37 1C. Death
curves were constructed by plotting log10 (CFU/mL) versus time.
Controls to assess contamination in juice or milk were done in all
sampling times, by performing the enumeration on PCA plates in
order to assess if any contaminant or resident microorganism was
present.
A panel of 12 trained subjects performed a sensory analysis.
The said subjects were selected for their sensory ability (in order
to achieve this purpose, three previous sensory tests were done,
viz. off-ﬂavor and basic taste identiﬁcation, as well as triangular
tests), and trained for descriptive analysis according to the
standard sensory proﬁle guidelines set by ISO 6564 (2003)
(to become familiar with the sensory vocabulary).
Sensory changes (perceived by aspect, ﬂavor and taste, as well
as texture) of the apple juice caused by the addition of 0.50% (w/v)
chitosan or COS were assessed via difference-from-control
test—in which apple juice was used as control. Previously, studies
with chitosan or COS added to milk samples were performed, but
unsatisfactory results were obtained by panel sensory evaluation,
in terms of visual and textural appearance. Each assessor smelled
and tasted the samples, and quantiﬁed them using a 3 to +3
continuous scale: 3 stand for the weakest and +3 for the
strongest.
Analyses were performed in triplicate, and each experiment
was carried out in duplicate. Mean values and standard deviations
were accordingly calculated from the experimental data obtained,
and analysis of variance (ANOVA) was applied at a 5% level of
signiﬁcance, using chitosan/COS concentration, chitosan type and0.6
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Fig. 1. MIC (&) and MLC (’) of chitosans of various MWs and chitooligosacchainoculum level as main factors. Pairwise comparisons were done
using Bonferroni’s test, at the same level of signiﬁcance.The antimicrobial activities of chitosans and COS are depicted
in Fig. 1. It can be easily observed that MICs and MLCs depend on
the bacterium being studied, and on the MW of the active
compound tested. Growth of E. coliwas markedly inhibited by COS
(Fig. 1a)—and the associated MICs were below 0.10% (w/v); this
threshold is lower than that reported elsewhere (Gerasimenko
et al., 2003)—1.0% (w/v) for a 5kDa oligomer effect on growth, but
slightly higher than that associated with a 6 kDa oligomer—0.06%
(w/v). Furthermore, the inhibitory effect decreased slightly as MW
increased—0.25% (w/v) of high MW chitosan was required
to inhibit growth of E. coli. In the case of S. aureus (Fig. 1b),
chitosans showed a stronger antibacterial activity than COS;
apparently, chitosans exhibit a stronger bactericidal effect upon
Gram-positive than Gram-negative bacteria (No et al., 2002). The
MICs varied from 0.10% (in the case of high and medium MW
chitosan) to 0.23% (w/v) (in the case ofo3kDa COS); these values
are relatively high when compared with those obtained by Jeon
et al. (2001)—0.06% and 0.12% (w/v) for chitosan and COS,
respectively. In addition, the differences found between MICs and
MLCs for S. aureus were more substantial than those obtained for
E. coli: MLCs of COS for S. aureus, ca. 0.5% (w/v), were indeed more
than 3-fold those of high and mediumMW chitosans, ca. 0.15% (w/v).
Differences in MIC (or MLC) values are recurrent in studies
encompassing chitosan, especially when various MWs are tested
in attempts to ﬁnd the one that exerts the highest antibacterial
effect. It has been claimed (Jeon et al., 2001) that 10 kDa is the
minimum MW required for inhibition; however, Zheng and Zhu
(2003) showed that a mixture of 0.25% (w/v) COS with MW
o5kDa yielded the highest inhibition over E. coli, whereas a
305kDa fraction had the highest effect against S. aureus, at a
similar concentration. Antibacterial activity over E. coli brought
about by oligomers (i.e. trimers to hexamers) was also reported
(Jeon and Kim, 2000)—even at 0.01% (w/v), while Ueno et al.
(1997) claimed that 2.2 kDa oligomers caused little effect on
microbial growth. Furthermore, the optimum MW found by Xia
et al. (1996) was 1.5 kDa; and No et al. (2002) reported that the
most effective MW against those two bacteria is 470kDa, when
the testing range was 1–1671kDa; in both cases, MICs were ca.0.6
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ARTICLE IN PRESS0.08% (w/v). The aforementioned differences are probably
accounted for by the distinct experimental conditions used by
different authors—viz. the MW range, the degree of deacetylation,
the concentration, the ﬁnal pH, the bacteria and chitosan sources,
and the solvents employed, among other variables (Wang, 1992).The effects of chitosan or COS at different concentrations upon
107 and 105 CFU/mL inocula of E. coli are depicted in Fig. 2. At the
lowest inoculum tested, i.e. 103 CFU/mL (results not shown), all
compounds revealed bactericidal activity, with viable numbers
reduced by up to 3 log cycles within 4h of exposure. In this case,
the most relevant features were the differences in time required to
achieve said reduction versus chitosan concentration and MW:
e.g. the o3kDa COS mixture needed 30min to achieve 99.9%
reduction at 0.50% (w/v), whereas 120min had to elapse for an
identical reduction in the case of 0.10% (w/v). The three chitosans
led, nevertheless, to similar results for the three concentrations: it
took 60, 120 and 240min for 0.1%, 0.25% and 0.50% (w/v) solutions
to attain a 3 log cycle reduction. These results are in agreement
with data published previously (Jeon and Kim, 2000; Liu et al.,
2001): the antibacterial effect upon E. coli was found to increase
with chitosan concentration, as in principle would be expected.
Regarding the higher inocula (i.e. 107 and 105 CFU/mL), our
results revealed similar tendencies; when a 107 CFU/mL inoculum
was used, only the COS mixtures showed bactericidal effect0.00001
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Fig. 2. Survival of E. coli, inoculated at 105 CFU/mL in M–H broth, in the presence of
COS with o3 ( ) and o5kDa ( ), and chitosans with low MW ( ),
medium MW ( ) and high MW ( ), at (a) 5.0mg/mL, (b) 2.5mg/mL and
1.0mg/mL (c), throughout incubation time (average7standard deviation).(i.e. a reduction by 99.9% of the initial viable numbers), at 0.5%
and 0.25% (w/v) (results not shown), whereas in general the three
chitosans led only to a minor reduction of the initial popula-
tion—not above 3 log cycles by 4h. At the lowest concentration,
0.10% (w/v), only the o3kDa COS mixture showed bactericidal
effect, although such an effect was rather similar to that of its
o5kDa COS counterpart. The medium and high MW chitosans
exhibited only a 2 log cycle reduction, but their low MW
counterpart showed a slightly stronger effect. At 105 CFU/mL
inoculum level, a solution of 0.50% (w/v) COS/chitosans (Fig. 2a)
produced a reduction above 3 log cycles, although it was attained
within different time periods—ca. 30min for COS, and more than
2h for chitosans. By 2h, the COS mixtures had essentially
eliminated the initial bacterial population; a 5 log cycle-reduction
in viable numbers was also achieved with 0.25% (w/v) COS
mixtures, but only by 4h (Fig. 2b)—these being the only two
compounds that produced a reduction above 99.9%. At this
inoculum level, both types of COS at 0.10% (w/v) led to a lower
reduction (3 log cycles) by 4h (Fig. 2c). The statistical analyses
applied to the whole dataset indicated that all three factors
(i.e. chitosan type, concentration and inoculum level) were
statistically signiﬁcant (po0.05); statistical signiﬁcance also held
for pairwise comparisons in terms of chitosan concentration and
inoculum level, although no signiﬁcant differences were found
between COS (o3 and o5kDa) and between chitosans (low,
medium and high MW).
The results obtained with S. aureuswere, in general, different—
and, in some cases, even opposite to those encompassing0.00001
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Fig. 3. Survival of S. aureus, inoculated at 105 CFU/mL in M–H, in the presence of
COS with o3 ( ) and o5kDa ( ), and chitosans with low MW ( ),
medium MW ( ) and high MW ( ), at (a) 5.0mg/mL, (b) 2.5mg/mL and
1.0mg/mL (c), throughout incubation time (average7standard deviation).
ARTICLE IN PRESSE. coli, especially concerning the effect of MW (Fig. 3). At the
lowest inoculum 103 CFU/mL (results not shown), all ﬁve
compounds tested exhibited a bactericidal effect against S. aureus.
At 0.50% (w/v), all those compounds required only 30min to
completely eliminate the initial population of S. aureus, whereas
high and medium MW chitosans at 0.25% (w/v) exerted their
activity earlier (by 30min) than the other three compounds
(by 60min). At the lowest concentration tested, high MW chitosan
was more efﬁcient—as it required only 1h, instead of 4h as found
for the other compounds, to essentially eliminate the initial
population. Analyzing the other two inocula (107 and 105 CFU/mL),
the inﬂuence of MW was not as pronounced as for E. coli. For both
inocula and for each of the three concentrations, a difference
above 1 log cycle was never observed throughout 4h for any of the
ﬁve different compounds. At 107 CFU/mL, the high MW chitosan
showed a stronger effect at all three concentrations tested (results
not shown), followed by the medium MW chitosan; these two
compounds were the only ones that presented a reduction higher
than 99.9% at 0.5% (w/v). For the three concentrations considered
and for both inoculum levels (107 and 105 CFU/mL), COS displayed
the lowest antibacterial activity (Fig. 3). All chitosans exposed to
the 105 CFU/mL inoculum caused a reduction above 99.9% at 0.5%
(w/v) (Fig. 3a). In the case of high and medium MW chitosans,
the 0.25% (w/v) concentration also showed bactericidal effect
(Fig. 3b)—which could not be observed for any of the compounds
tested at the lowest concentration, 0.10% (w/v) (Fig. 3c). The
analyses encompassing S. aureus indicated that all factors
(concentration, MW and inoculum level) were statistically
signiﬁcant (po0.05). However, pairwise comparisons revealed
signiﬁcant differences only between the extreme chitosan con-
centrations (i.e. 0.10% and 0.50%, w/v). The results encompassing
both S. aureus and E. coli showed a clear tendency concerning
inﬂuence of polymer chain length upon antibacterial action: the
antimicrobial effect was strongly dependent on the type of target
microorganism (Gram-negative versus Gram-positive) and the
MW of chitosan. Antimicrobial activity was observed for the
polymer with lower MW in the case of the Gram-negative
bacterium, and the reverse in the case of the Gram-positive one.
This conclusion is consistent with ﬁndings by other authors
(No et al., 2002; Xia and Wu, 1996); it was furthermore suggested00
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Fig. 4. Survival of (a) S. aureus and (b) E. coli in M–H broth, (c) S. aureus and (d) E. coli in
COS with o3 ( ) and o5kDa ( ), and chitosans with low MW ( ), med
(average7standard deviation). (Control, ).(Zheng and Zhu, 2003) that the apparent differential action upon
Gram-positive and Gram-negative microorganisms probably
results from the intrinsic difference in their cell wall structure:
it is easier for oligomers to penetrate the Gram-negative cell wall,
whereas a mechanical barrier is formed by higher MW chitosans
in their Gram-positive counterparts, which prevents nutrient
absorption. Using confocal laser scanning microscopy, it has been
shown (Liu et al., 2001) that COS actually penetrate E. coli cells,
hence suggesting that its antibacterial activity is chieﬂy caused by
inhibition of DNA transcription.The effect of MW upon the activity of chitosan against
S. aureus, in culture medium (used as control), is shown in Fig. 4a.
At the concentration selected 0.5% (w/v), all ﬁve compounds
showed bactericidal activity. Although every chitosan or COS
led to complete elimination of the initial population by 24h,
chitosans exhibited higher activity than COS at initial stages—a
difference of almost 2 log cycles was actually observed by 8h. As
described above for the 4h experiment, the COS mixtures
exhibited similar antimicrobial effect at that concentration,
whereas higher MW compounds showed a stronger activity.
Strong bactericidal activity was also observed towards E. coli, but
at different rates—COS needed only 2h, whereas chitosans
required an extra 6h to deplete the initial viable cells (Fig. 4b).
Concerning milk, it was possible to notice that after an initial
positive inhibitory effect that lasted for 8h, COS mixtures allowed
the viable counts of S. aureus to increase afterwards (Fig. 4c) until
they reached values similar to that of the control. This result is
likely explained by the high reactivity of those molecules with
milk proteins (e.g. casein), which are anionic molecules (Chakraborty
and Basak, 2007)—thus leading to loss of efﬁcacy, since a portion
of the COS molecules may be trapped in the protein network. This
loss of efﬁciency has been reported elsewhere (Ausar et al., 2002)
with milk fermentative bacteria: casein and milk fat, possibly due
to a strong interaction with these polymers, could act in a
competitive manner—and hence affect the antimicrobial activity
of chitosan, and especially COS. Devlieghere et al. (2004) also0
on time (h) Incubation time (h)
120100800 252015105
semi-skimmed milk, and (e) S. aureus and (f) E. coli in apple juice, in the presence of
ium MW ( ) and high MW ( ), at 5mg/mL, throughout incubation time
ARTICLE IN PRESSsuggested that such a phenomenon could result from competition
between negative charges on the milk protein and on the cell
surface of the microorganism, for the positive charges on chitosan.
However, for the three chitosans tested, no important differences
were observed, as the highest MW apparently prevented loss of
their antibacterial effect. In the case of E. coli (Fig. 4d), similar
results were obtained for COS; this conﬁrmed their strong
interaction with the constituents of the milk matrix. By 48h, only
medium and high MW chitosans exhibited bactericidal activity,
whereas low MW chitosan behavior resembled that of COS. In this
case, pH did not inﬂuence the antibacterial activity, as its ﬁnal
value was essentially similar in all cases—e.g. for E. coli and by
120h, the pH values of the solution with MW o3kDa COS, the
control and the high MW chitosan were 5.19, 5.32 and 5.41,
respectively.
The results obtained with apple juice showed some degree of
antimicrobial effect, even without addition of chitosans or COS:
the starting bacterial population vanished by 24h, most probably
due to the low pH prevailing in that food (ca. 3.85). When
chitosans or COS were added in the presence of S. aureus (Fig. 4e),
there was a high death rate in all cases—which was similar among
chitosans and COS: by 1h, initial viable counts were reduced
too10 CFU/mL by chitosans, whereas the same held for COS by
4h. When in the presence of E. coli (Fig. 4f), the aforementioned
compounds required 4h to cause depletion (i.e. a 5 log cycle
reduction) of the bacteria. Accordingly, such a fast action of
chitosans and hydrolysates there of may be explained by
the lower pH of this matrix—in agreement with claims by
other authors (Roller and Covill, 1999; Tsai and Su, 1999; Wang,
1992) that the antimicrobial activity of chitosan is affected
by pH, with a higher activity being recorded at a lower
pH. For both microorganisms tested, the effect of the food
matrix was found to be statistically signiﬁcant (po0.05),
as well as the MW and the incubation time. However, pairwise
comparisons revealed no statistically signiﬁcant differences
between COS (o3 and o5kDa), and between medium and high
MW chitosans.Table 1
Sensory differences assessed by a group of trained panellists, between apple juice
containing 0.50% (w/v) of chitosan/COS, and plain apple juice (control), expressed
in a scale ranging from 3 to 3 : 3 ¼ weaker than, 0 ¼ equal to, and 3 ¼ stronger
than (average7standard deviation)
Control High MW Low MW COS o3kDa
Aspect
Color 0.170.2 1.170.1 1.370.1 2.170.1
Translucency 0.070.1 0.270.2 0.170.2 0.070.2
Aroma
Global intensity 0.070.0 0.970.3 0.670.2 0.570.2
Fresh apple 0.270.4 0.770.3 0.470.3 0.170.2
Boiled apple/apple jam 0.170.4 0.270.3 0.370.3 0.770.2
Others (seafood) 0.070.0 1.570.2 0.270.2 0.370.1
Taste
Sweetness 0.270.1 0.370.3 0.170.5 0.470.3
Acidity 0.270.1 1.070.2 1.270.2 0.270.1
Intensity 0.270.1 0.370.5 0.870.4 0.370.3
Fresh apple 0.170.1 1.670.3 1.270.2 0.270.2
Boiled apple/apple jam 0.170.3 0.970.5 0.470.4 0.570.3
Richness 0.170.1 0.170.4 0.270.5 0.170.2
Persistence 0.370.1 1.170.4 0.270.6 0.670.2
After taste 0.370.1 1.770.4 1.570.5 0.970.3
Others (bitter) 0.070.0 2.470.2 2.170.0 0.070.0
Texture
Texture in mouth/viscosity 0.070.0 1.470.3 1.670.3 0.770.4
Astringency 0.270.1 2.370.1 2.470.2 1.370.3When milk was used as model food, relatively large clusters
formed by 2–4h in presence of COS mixtures, when exposed to
either microorganism. Conversely, no clusters were formed for
high and medium MW chitosans, rather a net-like structure
developed all over the food matrix. The ﬁve compounds produced
changes that made the semi-skimmed milk unsuitable for
consumption—from visual and textural points of view, so no
further sensory testing was warranted. Concerning apple juice,
such unfavorable changes were not perceived, so it was formally
submitted to evaluation by a trained panel. The results (Table 1)
showed a general trend: an increase in the magnitude of changes
with an increase in MW. Such undesirable characteristics as
astringency, after taste or high viscosity were more noticeable
when chitosans were added—especially high MW ones, than
when COS mixtures were considered. In addition, characteristics
desirable for apple juice, e.g. taste or aroma of fresh apples, tended
to vanish as the MW increased. Furthermore, COS maintained
several typical characteristics of traditional apple juice—viz
sweetness and acidity, or resembled even more the apple
feedstock—with references to boiled apple/apple jam keynotes.The antimicrobial effect of chitosans is strongly dependent on
the type of target microorganism (Gram-negative versus Gram-
positive) and the MW of chitosan—being higher for lower MW in
the case of the Gram-negative bacterium, and the reverse in the
case of the Gram-positive one. The stronger antibacterial activity
observed, at lower pH, in the juice matrix, coupled with the poor
performance of the milk matrix, suggest that the use of chitosans
(irrespective of MW) will be limited to food products that possess
a low protein content. However, the interference of proteins upon
chitosan/COS inhibiting effects decreases with increase of MW.
Chitosans and oligomers thereof are also more effective as food
preservatives in low pH foods. Finally, COS appear in general as
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